Enable Injections’ enFuse Syringe Transfer System has secured CE mark approval under the European Union Medical Device ...

Enable Injections announced today that it received CE mark approval for its EnFuse syringe transfer system for drug delivery.

Objective—We aimed to establish the ideal injection techniques using 5-mm needles to reliably inject insulin into the subcutaneous fat in both children and adults and to quantify the associated ...

The team from Massachusetts Institute of Technology (MIT) have suggested that the technology could be useful for applications ...

Enable is currently working with a number of pharmaceutical partners to conduct clinical trials and plan for joint commercial launch of their therapies in combination with the enFuse technology. The ...

Zepbound comes as a solution in a single-dose prefilled pen or single-dose vial for use with a syringe and needle (which are not included). It’s given as a subcutaneous injection. With a ...

The LifeSite subcutaneous access ... antibiotic prophylaxis. This injection of 70% IPA is performed before and after each dialysis session. Because the 25-gauge needle does not open the internal ...

Insulin is injected subcutaneously, or into the fat layer under the skin. In this type of injection, a short needle is used to inject insulin into the fatty layer between the skin and the muscle.

Patient adherence and persistence with injection-based chronic therapy regimes are notoriously low owing to, among other factors, needle anxiety ... to reach the desired subcutaneous space ...